Sellbyville, DE -- (SBWIRE) -- 05/23/2019 -- Global Biotechnology Market is set to exceed USD 775 billion by 2024; according to a new research report by Global Market Insights. Growing incidence of chronic diseases will boost biotechnology market growth over the forecast timeline. According to the World Economic Forum 2017 data, with every chronic condition, annual healthcare costs increase. Additionally, with each chronic condition, average medical payments that are more than double, suggest that chronic conditions might interrelate to increase in healthcare costs. Ongoing developments and progress in various segments of biotechnology to overcome the burden of these chronic conditions should further foster biotechnology industry growth.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/784

Innovations in biotechnology sector is expected to upsurge revenue size during the forecast period. Innovations such as growing human organs, laboratory grown plants and meat coupled with rising demand for novel biotechnological products will favor business growth. Moreover, increasing demand for agriculture based products should enhance biotechnology industry growth over the coming years. However, there are some negative effects and risks such as risk related to genetic data that can hamper biotechnology market growth over the forthcoming years.

Bioservices segment will show 11.4% CAGR over forthcoming years and segmental growth will be accredited to rising clinical research initiatives by several pharmaceutical and biotechnology firms. Bioagriculture segment was valued at USD 40.0 billion in 2017 and is estimated to grow significantly over the projected timeframe. Suring demand for agricultural products coupled with developments in bioagriculture field increases segmental revenue share.

Bioagriculture segment was valued at USD 40.0 billion in 2017 and is estimated to grow significantly over the projected timeframe. Suring demand for agricultural products coupled with developments in bioagriculture field increases segmental revenue share.Nanobiotechnology segment accounted for 10.6% revenue share in 2017. The segmental growth is attributable to growing demand in stem cell therapy, expansion capabilities in zones of forensic science and forensic diagnostics.

U.S. biotechnology market dominated North America region in 2017 and will continue to project similar trend with 11.1% CAGR during analysis timeframe. High growth is attributable to factors such as innovative technologies and presence of favorable government initiatives. Furthermore, advanced healthcare infrastructure and rising R&D spending should further spur revenue size.

Nanobiotechnology segment accounted for 10.6% revenue share in 2017. The segmental growth is attributable to growing demand in stem cell therapy, expansion capabilities in zones of forensic science and forensic diagnostics. U.S. biotechnology market dominated North America region in 2017 and will continue to project similar trend with 11.1% CAGR during analysis timeframe. High growth is attributable to factors such as innovative technologies and presence of favorable government initiatives. Furthermore, advanced healthcare infrastructure and rising R&D spending should further spur revenue size.

India biotechnology market is projected to show lucrative and was valued at USD 15.9 billion in 2017 during forecast timeframe due to rising prevalence of chronic diseases in the country. According to the National Center for Biotechnology Information (NCBI) 2015 data, chronic conditions are on rise in India as well as on global level. Additionally, predominant intra-urban disproportions for access to healthcare services complexes the problems that are tackled by urban poor individuals. Moreover, high unmet needs and insufficient healthcare access are factors boosting demand for biotechnology thereby fostering business growth.

Prominent business competitors operating in the biotechnology market include Agilent Technologies, Amgen, Abbott Laboratories, Bio-Rad Laboratories, BioGen Medical Instruments, Danaher, Merck, F. Hoffmann-La Roche, Illumina, PerkinElmer, Thermo Fisher Scientific and Qiagen.

Biotechnology Market, By Application (USD Billion)

1 Biopharmacy
2 Bioservices
3 Bioagriculture
4 Bioindustrial
5 Bioinformatics

Biotechnology Market, By Technology (USD Billion)

1 Fermentation
2 Tissue engineering and regeneration
3 PCR technology
4 Nanobiotechnology
5 Chromatography
6 DNA sequencing

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/784

Chapter 1. Methodology

1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary

Chapter 2. Executive Summary

2.1. Biotechnology Market 3600 synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Application trends
2.1.3. Technology trends
2.1.4. Regional trends

Chapter 3. Biotechnology Industry Insights

3.1. Industry segmentation
3.2. Industry landscape, 2013 - 2024
3.3. Industry impact forces

3.3.1. Growth drivers
3.3.1.1. Presence of favorable government initiatives in developed countries
3.3.1.2. Innovative technologies
3.3.1.3. Rising demand for agriculture-based products
3.3.1.4. Growing incidence of chronic ailments worldwide

Chapter 4. Biotechnology Market, By Application

4.1. Key segment trends

4.2. Biopharmacy
4.2.1. Market size, by region, 2013-2024 (USD Billion)

4.3. Bioservices
4.3.1. Market size, by region, 2013-2024 (USD Billion)

4.4. Bioagriculture
4.4.1. Market size, by region, 2013-2024 (USD Billion)

4.5. Bioindustrial
4.5.1. Market size, by region, 2013-2024 (USD Billion)

4.6. Bioinformatics
4.6.1. Market size, by region, 2013-2024 (USD Billion)

Browse Full Report Details @ https://www.gminsights.com/industry-analysis/biotechnology-market

Data Tables

TABLE 1 Biotechnology industry 3600 synopsis, 2013 – 2024
TABLE 2 Biotechnology market, 2013-2017 (USD Billion)
TABLE 3 Biotechnology market, 2018-2024 (USD Billion)
TABLE 4 Biotechnology market, by application, 2013-2017 (USD Billion)
TABLE 5 Biotechnology market, by application, 2018-2024 (USD Billion)
TABLE 6 Biotechnology market, by technology, 2013-2017 (USD Billion)
TABLE 7 Biotechnology market, by technology, 2018-2024 (USD Billion)
TABLE 8 Biotechnology market, by region, 2013-2017 (USD Billion)
TABLE 9 Biotechnology market, by region, 2018-2024 (USD Billion)